Real-time enrollment status for this amyloidosis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:46 AM UTC
| NCT Number | NCT07224672 |
| Recruiting Status | Recruiting |
| Condition | Amyloidosis |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 31, 2026: Clinical trial NCT07224672 is currently recruiting participants. This phase2 study for amyloidosis is actively seeking new participants at 1 location across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07224672 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07224672 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.